- Report
- September 2026
- 188 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- February 2026
- 160 Pages
Global
From €3107EUR$3,320USD£2,597GBP
€3884EUR$4,150USD£3,247GBP
- Report
- February 2026
- 250 Pages
Global
From €4202EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4202EUR$4,490USD£3,513GBP
- Report
- September 2026
- 182 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- July 2024
- 100 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- October 2025
- 160 Pages
Global
From €2958EUR$3,160USD£2,472GBP
€3697EUR$3,950USD£3,090GBP
- Report
- December 2023
- 1362 Pages
Global
From €9355EUR$9,995USD£7,819GBP
- Report
- May 2023
- 117 Pages
Global
From €3500EUR$4,006USD£3,028GBP
- Report
- May 2023
- 81 Pages
Global
From €3500EUR$4,006USD£3,028GBP
The Patent Foramen Ovale (PFO) Device market is a subset of the Cardiovascular Devices market. It is composed of medical devices used to close a hole in the heart, known as a patent foramen ovale (PFO). This hole is a natural opening between the two upper chambers of the heart, and it is present in about 25% of the population. PFO closure devices are used to reduce the risk of stroke and other neurological events. These devices are typically implanted during a minimally invasive procedure, and they are designed to remain in place for the lifetime of the patient.
The PFO Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Boston Scientific, W.L. Gore & Associates, and Occlutech. Show Less Read more
